Markus Mueller is the co-founder of GauVendi, bringing 25+ years of leadership in tourism across Europe, the Middle East, the Caribbean, and Asia, working with Mövenpick, Hyatt, IHG, and Marriott. He holds an MBA with Distinction from Warwick Business School.
As a founder, he has pioneered a new way to manage, price, and sell real estate-based experiences, using AI-driven dynamic matching to connect properties with travelers—enabling personalized stays instead of generic room bookings. His innovations have led to 20% higher revenues, 70% automation of reservation processes, and a 30% increase in Net Promoter Scores.
Sean Smith is a Biological Threat Exclusion Coordinator (BTEC) for U.S. Customs and Border Protection (CBP) in the Office of Field Operations
Agriculture Programs and Trade Liaison/ Biological Threat Exclusion. As a BTEC, Mr. Smith is charged with supporting and developing CBP operational capacity and capability in preventing tools of agro/bio-terrorism from entering the U.S. Mr. Smith has more than 18 years of public service with CBP, and has worked in a variety of environments, including on the southern land border, maritime, air passenger, and cargo locations. He has also been able to assist in several past domestic and international CBP disaster recovery operations.
David Admas David is a top performing Clinical Supply Chain Manager with over 15 years of pharmaceutical experience, ranging from stability testing, clinical packaging & labeling, and global clinical supply chain management. He is both a leader and contributing member to many process improvement workstreams at Takeda that include being the Head of the Label Focus Group, developing and implementing clinical label text translation phrase library, guidance on Compassionate Use clinical programs, decentralized trials, and is the packaging & labeling subject matter expert for the Clinical Supply team. David has presented at CTS conferences before on the topic of Direct-to-Patient delivery of IP supplies, but today is here to speak about best practices for Comparator Sourcing and Labeling.
John Gregg, Pharmaceutical industry executive, John Gregg, has extensive experience in worldwide clinical development and commercialization of new anti-infective drugs. He has spent much of his career in senior roles directing the development and commercialization efforts for a large number of antibiotic, anti-protozoal, anti-fungal and anti-viral drugs. He is a veteran of new product development leadership positions at Pfizer, Novartis, J&J, BMS, and more recently his start-ups, Symbiomix Therapeutics, LifeQual Pharmaceuticals, and AkaRx. He is now the CEO of a BalinBac Therapeutics, Inc., a specialty infectious disease and microbiome modulation company. He was trained as a microbiologist and has led multi-disciplinary anti-infective drug development teams at the largest pharmaceutical companies, as well as small, private specialty firms directing the work of colleagues and contract laboratories
BS Chemistry from University of Minnesota in 2017
PharmD from University of Minnesota College of Pharmacy in 2022
Started as postdoctoral fellow in global clinical supply chain at Takeda in July 2022
Fred Moreau is the Director of Centralized Ancillary Supply Management at Takeda Pharmaceuticals. His responsibilities include development & implementation of supply strategies to facilitate and support the delivery of ancillary supplies.
Fred has over 20 years of experience in the pharmaceutical and medical device industry. In his career he has been responsible for clinical and commercial supply planning for multiple programs; product lifecycle management; strategic sourcing; and planning for new product launches.
Tomasz Adamusiak, MD PhD, serves as the Chief Scientist for Clinical Quality and Data Science at MITRE, where he leads initiatives to improve healthcare outcomes through AI and real-world evidence. Previously, as Head of Data Science at the Pfizer Innovation Research Lab, he led work on digital endpoints and decentralized clinical trials. He has held leadership positions within the American Medical Informatics Association and SNOMED International, and has published extensively in peer-reviewed journals.
